Our top pick for
US stocks
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Universal Biosensors is a medical devices business based in Australia. Universal Biosensors shares (UBI) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Universal Biosensors has a trailing 12-month revenue of around $6 million. If you're looking to buy shares, check out the steps below.
How to buy shares in Universal Biosensors
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the ASX. Our table can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, such as your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Universal Biosensors. Find the share by name or ticker symbol: UBI. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Universal Biosensors reaches your desired price. Look into dollar-cost averaging to spread out your risk, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check on your investment. Congratulations, you own a part of Universal Biosensors. Optimise your portfolio by tracking how your stock and the business performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that affect your stock.
Our top pick for
Long-term investing
Our top pick for
Low-cost broker
What's in this guide?
Universal Biosensors stock price (ASX:UBI)
Use our graph to track the performance of UBI stocks over time.Universal Biosensors shares at a glance
Information last updated 2022-06-22.
| 52-week range | $0.31 - $1.04 |
|---|---|
| 50-day moving average | $0.54 |
| 200-day moving average | $0.7842 |
| Target price | $1.13 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.077 |
Compare share trading platforms
The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
1 - 9 of 9
Is it a good time to buy Universal Biosensors stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Universal Biosensors price performance over time
Historical closes compared with the last close of A$0.355
| 1 month (2022-05-27) | -19.32% |
|---|---|
| 3 months (2022-03-28) | -57.23% |
| 6 months (2021-12-24) | -60.56% |
| 1 year (2021-06-28) | -55.63% |
|---|---|
| 2 years (2020-06-26) | 77.50% |
| 3 years (2019-06-28) | 63.22% |
Is Universal Biosensors under- or over-valued?
Valuing Universal Biosensors stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Universal Biosensors's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Universal Biosensors's EBITDA
Universal Biosensors's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $41.9 million (£0.0 million).
The EBITDA is a measure of a Universal Biosensors's overall financial performance and is widely used to measure a its profitability.
Universal Biosensors financials
| Revenue TTM | $6 million |
|---|---|
| Gross profit TTM | $2.1 million |
| Return on assets TTM | -23.42% |
| Return on equity TTM | -45.56% |
| Profit margin | -228.64% |
| Book value | 0.13 |
| Market capitalisation | $59.4 million |
TTM: trailing 12 months
Universal Biosensors share dividends
We're not expecting Universal Biosensors to pay a dividend over the next 12 months.
Universal Biosensors share price volatility
Over the last 12 months, Universal Biosensors's shares have ranged in value from as little as $0.31 up to $1.04. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Universal Biosensors's is 1.204. This would suggest that Universal Biosensors's shares are a little bit more volatile than the average for this exchange and represent, relatively speaking, a slightly higher risk (but potentially also market-beating returns).
Universal Biosensors overview
Universal Biosensors, Inc., through its subsidiary, Universal Biosensors Pty Ltd, operates as a biosensors company primarily in Australia. The company focuses on the development, manufacture, and commercialization of point-of-use devices for measuring analytes across various industries. It manufactures and distributes Prothrombin Time International Normalized Ratio coagulation test strips; and distributes Siemens' Xprecia Stride Coagulation Analyzer, a test used to monitor the effect of the anticoagulant therapy warfarin. The company also manufactures and distributes Sentia SO2 test strips; and distributes Sentia Analyzer for the use in measurement of free SO2 levels in post-fermentation wine. In addition, it offers non-diagnostic laboratory services and performs coagulation testing services. The company has a license agreement with LifeScan Global Corporation to develop a biosensor strip and a meter to be used for the detection and monitoring of diabetes in animals. Universal Biosensors, Inc. was incorporated in 2001 and is headquartered in Rowville, Australia.
Universal Biosensors in the news
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
-
How to invest in the Australia Sunny Glass Group IPO
Everything we know about the Australia Sunny Glass Group IPO, plus information on how to buy in.
-
How to buy Kincora Copper (KCC) shares
Steps to owning and managing Kincora Copper shares.
-
How to invest in the Dragon Mountain Gold IPO
Everything we know about the Dragon Mountain Gold IPO, plus information on how to buy in.
-
How to buy Arcadia Minerals (AM7) shares
Steps to owning and managing Arcadia Minerals shares.
-
How to buy Nexgen Energy (NXG) shares
Steps to owning and managing Nexgen Energy shares.
-
How to buy Keypath Education (KED) shares
Steps to owning and managing Keypath Education shares.
-
What are green bonds and how do they impact the world?
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
-
5 best ways to invest money in Australia in 2022
What's the best way to invest money in Australia? Find out about robo advisors, index funds, cryptocurrency and more in this guide.
-
How to buy EBR Systems (EBR) shares
Steps to owning and managing EBR Systems shares.
-
How to buy 5E Advanced Materials (5EA) shares
Steps to owning and managing 5E Advanced Materials shares.
Ask an Expert
